These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 19267297

  • 1. Development and release mechanism of diltiazem HCl prolonged release matrix tablets.
    Boyapally H, Nukala RK, Douroumis D.
    Drug Deliv; 2009 Feb; 16(2):67-74. PubMed ID: 19267297
    [Abstract] [Full Text] [Related]

  • 2. In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures.
    Vueba ML, Batista de Carvalho LA, Veiga F, Sousa JJ, Pina ME.
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1651-62. PubMed ID: 23094867
    [Abstract] [Full Text] [Related]

  • 3. [Preparation of diltiazem hydrochloride delayed-onset, sustained release tablet].
    Zhang N, Zhu JB.
    Yao Xue Xue Bao; 2002 Sep; 37(9):724-7. PubMed ID: 12567900
    [Abstract] [Full Text] [Related]

  • 4. Modulation of drug release by utilizing pH-independent matrix system comprising water soluble drug verapamil hydrochloride.
    Baviskar D, Sharma R, Jain D.
    Pak J Pharm Sci; 2013 Jan; 26(1):137-44. PubMed ID: 23261739
    [Abstract] [Full Text] [Related]

  • 5. [Modern polymers in matrix tablets technology].
    Zimmer Ł, Kasperek R, Poleszak E.
    Polim Med; 2014 Jan; 44(3):189-96. PubMed ID: 25739125
    [Abstract] [Full Text] [Related]

  • 6. Drug release-modulating mechanism of hydrophilic hydroxypropylmethylcellulose matrix tablets: distribution of atoms and carrier and texture analysis.
    Park JB, Lim J, Kang CY, Lee BJ.
    Curr Drug Deliv; 2013 Dec; 10(6):732-41. PubMed ID: 23855499
    [Abstract] [Full Text] [Related]

  • 7. Application of similarity factor in development of controlled-release diltiazem tablet.
    Peh KK, Wong CF.
    Drug Dev Ind Pharm; 2000 Jul; 26(7):723-30. PubMed ID: 10872090
    [Abstract] [Full Text] [Related]

  • 8. Advanced formulation design of venlafaxine hydrochloride coated and triple-layer tablets containing hypromellose.
    Gohel M, Bariya SH.
    Pharm Dev Technol; 2009 Jul; 14(6):650-8. PubMed ID: 19883254
    [Abstract] [Full Text] [Related]

  • 9. An innovative matrix controlling drug delivery produced by thermal treatment of DC tablets containing polycarbophil and ethylcellulose.
    Caviglioli G, Baldassari S, Cirrincione P, Russo E, Parodi B, Gatti P, Drava G.
    Int J Pharm; 2013 Dec 15; 458(1):74-82. PubMed ID: 24144954
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Characterization of 5-fluorouracil release from hydroxypropylmethylcellulose compression-coated tablets.
    Wu B, Shun N, Wei X, Wu W.
    Pharm Dev Technol; 2007 Dec 15; 12(2):203-10. PubMed ID: 17510892
    [Abstract] [Full Text] [Related]

  • 12. A new ternary polymeric matrix system for controlled drug delivery of highly soluble drugs: I. Diltiazem hydrochloride.
    Kim H, Fassihi R.
    Pharm Res; 1997 Oct 15; 14(10):1415-21. PubMed ID: 9358555
    [Abstract] [Full Text] [Related]

  • 13. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC.
    Sankalia JM, Sankalia MG, Mashru RC.
    J Control Release; 2008 Jul 02; 129(1):49-58. PubMed ID: 18456362
    [Abstract] [Full Text] [Related]

  • 14. Modulation of drug (metoprolol succinate) release by inclusion of hydrophobic polymer in hydrophilic matrix.
    Siddique S, Bose A, Khanam J.
    Drug Dev Ind Pharm; 2011 Sep 02; 37(9):1016-25. PubMed ID: 21401340
    [Abstract] [Full Text] [Related]

  • 15. Floating elementary osmotic pump tablet (FEOPT) for controlled delivery of diethylcarbamazine citrate: a water-soluble drug.
    Khan ZA, Tripathi R, Mishra B.
    AAPS PharmSciTech; 2011 Dec 02; 12(4):1312-23. PubMed ID: 21969244
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Drug-polymer mixed coating: a new approach for controlling drug release rates in pellets.
    Nisar ur Rahman, Yuen KH, Khan NA, Wong JW.
    Pharm Dev Technol; 2006 Feb 02; 11(1):71-7. PubMed ID: 16544910
    [Abstract] [Full Text] [Related]

  • 18. [Optimization of the formulation of ranolazine hydrochloride sustained-release tablet and its pharmacokinetics in dogs].
    Li CJ, Yu YL, Yang QM, Li Y, Zhang YH, Wang JY.
    Yao Xue Xue Bao; 2010 Sep 02; 45(9):1170-6. PubMed ID: 21351575
    [Abstract] [Full Text] [Related]

  • 19. Formulation development and evaluation of Diltiazem HCl sustained release matrix tablets using HPMC K4M and K100M.
    Qazi F, Shoaib MH, Yousuf RI, Qazi TM, Mehmood ZA, Hasan SM.
    Pak J Pharm Sci; 2013 Jul 02; 26(4):653-63. PubMed ID: 23811439
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.